InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Rhythm Biosciences Limited (ASX: RHY) - Announcements

- Current share price for RHY : $0.065

ASX company news and announcements for Rhythm Biosciences Limited (RHY) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Rhythm Biosciences Limited (RHY) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Rhythm Biosciences Limited (RHY), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Rhythm Biosciences Limited (RHY)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$23 Market Update 16 Feb 2024 9:48AM $0.120 $0.065 fallen by 45.83%
$23 Results of Extraordinary General Meeting 12 Feb 2024 1:09PM $0.125 $0.065 fallen by 48%
$23 EGM Slides 12 Feb 2024 1:05PM $0.125 $0.065 fallen by 48%
$23 Proposed issue of securities - RHY 9 Feb 2024 10:14AM $0.175 $0.065 fallen by 62.86%
$23 Rights Issue Offer to Raise Up To $6.6 million 9 Feb 2024 10:14AM $0.175 $0.065 fallen by 62.86%
$23 Update re EGM 12 February 2024 8 Feb 2024 2:06PM $0.175 $0.065 fallen by 62.86%
$23 Trading Halt 7 Feb 2024 8:59AM $0.175 $0.065 fallen by 62.86%
$23 Quarterly Activities Report and Appendix 4C - Dec23 31 Jan 2024 10:31AM $0.135 $0.065 fallen by 51.85%
$23 2024 EGM Notice of Meeting 4 Jan 2024 11:19AM $0.125 $0.065 fallen by 48%
$23 Appendix 3Z - Final Directors Interest Notice 29 Dec 2023 8:35AM $0.120 $0.065 fallen by 45.83%
$23 Resignation of Dr Rachel David as Non-executive Director 29 Dec 2023 8:34AM $0.120 $0.065 fallen by 45.83%
$23 Strategy & Market Update 18 Dec 2023 8:30AM $0.185 $0.065 fallen by 64.86%
$23 Receipt of Notice under Section 249D of the Corporations Act 15 Dec 2023 8:58AM $0.150 $0.065 fallen by 56.67%
$23 Becoming a substantial holder 14 Dec 2023 8:01PM $0.150 $0.065 fallen by 56.67%
$23 Appointment of Joint Company Secretary 14 Dec 2023 8:46AM $0.150 $0.065 fallen by 56.67%
$23 Platform Expansion - Lung Cancer Diagnostic Test Update 24 Nov 2023 8:44AM $0.180 $0.065 fallen by 63.89%
$23 Executive Management Changes 15 Nov 2023 4:50PM $0.200 $0.065 fallen by 67.50%
$23 Receipt of First Tranche of $1.69m in R&D Tax Incentive 14 Nov 2023 9:23AM $0.210 $0.065 fallen by 69.05%
$23 Appendix 4C and Market Update 31 Oct 2023 9:26AM $0.175 $0.065 fallen by 62.86%
$23 Appendix 3Y - Change of Directors Interest Notice 24 Oct 2023 1:52PM $0.175 $0.065 fallen by 62.86%
$23 Notification regarding unquoted securities - RHY 24 Oct 2023 12:06PM $0.175 $0.065 fallen by 62.86%
$23 Response to ASX Query 18 Oct 2023 12:39PM $0.170 $0.065 fallen by 61.76%
$23 Response to ASX Price Query 13 Oct 2023 10:54AM $0.185 $0.065 fallen by 64.86%
$23 Pause in Trading 13 Oct 2023 9:56AM $0.185 $0.065 fallen by 64.86%
$23 Becoming a substantial holder 12 Oct 2023 4:53PM $0.185 $0.065 fallen by 64.86%

251 - 275 of 654 results

Page 11 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.